1. BACK TO SCHOOL: Communicating with the Team

    Posted on August 22, 20164:33 pm

      Guest blog by Celeste Graham, PT, Director of Physical Therapy, CureDuchenne Cares We are at that time of year when the shelves of our local superstores that just recently held beach towels and sunscreen are already being replaced with pencils, binders and backpacks . . . it is BACK TO SCHOOL time!     Read more »

  2. Navigating College, Living with Duchenne

    Posted on August 16, 20167:19 pm

      Guest blog by Hawken Miller For those with Duchenne Muscular Dystrophy the experience and education of a four-year university is likely within your grasp, and being away from home is a definite possibility. I’ll admit, I had my own second thoughts about going off to college, but it is worth it once you move Read more »

  3. Pfizer, Bamboo and CureDuchenne – An Endorsement on the Right Track

    Posted on August 1, 20167:24 pm

      Today, we are very pleased to announce that Pfizer has acquired Bamboo Therapeutics, a gene therapy company we invested in earlier this year through CureDuchenne Ventures. The deal is valued at up to $645 million. Bamboo, led by Dr. Richard Jude Samulski, PhD, the Director of the Gene Therapy Center at UNC, and Dr. Xiao Read more »